首页|期刊导航|中国肺癌杂志|PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer

PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer

Jing LI Lin QI Mingfang ZHANG Caiyun YAO Jinan FENG Zhonghua ZHENG Chujia CHEN Shiwei DUAN Yuanlin QI

中国肺癌杂志2022，Vol.25Issue(2)：78-85,8.

中国肺癌杂志2022，Vol.25Issue(2)：78-85,8.DOI:10.3779/j.issn.1009-3419.2022.102.03

PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer

Jing LI ¹Lin QI ¹Mingfang ZHANG ¹Caiyun YAO ¹Jinan FENG ¹Zhonghua ZHENG ²Chujia CHEN ²Shiwei DUAN ²Yuanlin QI¹

作者信息

1. School of Basic Medical Sciences,Fujian Medical University,Fuzhou 350122,China
2. Medical Genetics Center,School of Medicine,Ningbo University,Ningbo 315211,China
折叠

摘要

关键词

Lung neoplasms/PRKCDBP/DNA methylation

Key words

Lung neoplasms/PRKCDBP/DNA methylation

引用本文复制引用

Jing LI,Lin QI,Mingfang ZHANG,Caiyun YAO,Jinan FENG,Zhonghua ZHENG,Chujia CHEN,Shiwei DUAN,Yuanlin QI..PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer[J].中国肺癌杂志,2022,25(2):78-85,8.

基金项目

The research was supported by the grants from National Natural Science Foundation of China(to Yuanlin QI,No.81773055),Natural Science Foundation of Fujian Province(to Yuanlin QI,No.2018J01829 and to Mingfang ZHANG,No.2019J01293),Key Talents Training Program of Fujian Provincial Health Commission(to Yuanlin QI,No.2017-ZQN-59 and to Mingfang ZHANG,No.2017-ZQN-60),Joint Funds for the Innovation of Science and Technology of Fujian Province(to Yuanlin QI,No.2017Y9113),and K.C.Wong Magna Fund in Ningbo University(to Shiwei DUAN). （to Yuanlin QI,No.81773055）

中国肺癌杂志

OA北大核心CSCDCSTPCDMEDLINE

ISSN：1009-3419

访问量0

下载量0

段落导航